Tag: labeling

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Telit Cinterion Enhances deviceWISE® AI Visual Inspection with NVIDIA TAO 6.0 Integration to Improve Industrial IoT Automation

The NVIDIA TAO 6.0 integration delivers advanced foundation models, fine-tuning capabilities, prompt‑based segmentation, and in‑context segmentationManufacturers benefit from enhanced tools for on-premises inferencing and...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global Phase III trials to demonstrate statistically significant reduction in...

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Ad hoc announcement pursuant to Art. 53 LR

SharpVision: Advanced Vision Support Supplement for Clearer, Healthier Eyes in 2025

How Ingredient Transparency, Screen-Time Trends, and Clean-Label Formulas Are Shaping the Vision Wellness Movement in 2025

How Ingredient Transparency, Screen-Time Trends, and Clean-Label Formulas Are Shaping the Vision Wellness Movement in 2025

Where Food Comes From, Inc. Reports 2025 Second Quarter Financial Results

Second Quarter Highlights – 2025 vs. 2024

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsLabeling

Liftoff Announces Pricing of Initial Public Offering

Andrew Peller Ltd. Announces Timing of Q4 & Full-Year Fiscal 2026 Results & Conference Call

Simplify Labs: No MiCA License Yet? Here’s How You Can Still Launch Your Crypto Exchange in Europe

Tag: labeling

Novartis ianalumab Phase III trial meets primary endpoint in ITP, demonstrating statistically significant improvement in time to treatment failure

Telit Cinterion Enhances deviceWISE® AI Visual Inspection with NVIDIA TAO 6.0 Integration to Improve Industrial IoT Automation

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease

SharpVision: Advanced Vision Support Supplement for Clearer, Healthier Eyes in 2025

Where Food Comes From, Inc. Reports 2025 Second Quarter Financial Results

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us